Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00032260.xml
Digestive Disease Interventions 2022; 06(02): 075-085
DOI: 10.1055/s-0042-1748021
DOI: 10.1055/s-0042-1748021
Review Article
Portal Hypertension: Current Surgical Management
Abstract
Portal hypertension occurs due to multiple disorders of the liver and its circulation. It is defined as an elevated pressure gradient between the portal circulation and the systemic circulation. The primary clinical consequences of portal hypertension are ascites and the development of portosystemic varices, which may cause life threatening hemorrhage. Modern management of portal hypertension includes medical, endoscopic therapy and transjugular intrahepatic portosystemic shunt placement by interventional radiology. Historically, portal hypertension was treated through the creation of surgical portosystemic shunts. In this chapter, the physiology of portal hypertension and the approaches to its management will be discussed. Specifically, the chapter will focus on indications, technical considerations, and types of surgical shunts used to treat portal hypertension, as well as literature supporting these procedures. Three case reports describing recent successful surgical shunt creation will be presented. Although portosystemic surgical shunt creation is performed far less frequently as medical, endoscopic and radiologic interventions have improved, this chapter illustrates that this procedure is a vital tool to be used in the treatment of portal hypertension.
Keywords
portal hypertension - transjugular intrahepatic portosystemic shunt - surgical portosystemic shunts - outcomesPublication History
Received: 06 December 2021
Accepted: 24 January 2022
Article published online:
13 June 2022
© 2022. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Simonetto DA, Liu M, Kamath PS. Portal Hypertension and Related Complications: Diagnosis and Management. Mayo Clin Proc 2019; 94 (04) 714-726 DOI: 10.1016/j.mayocp.2018.12.020.
- 2 Turco L, Garcia-Tsao G. Portal Hypertension: Pathogenesis and Diagnosis. Clin Liver Dis 2019; 23 (04) 573-587 DOI: 10.1016/j.cld.2019.07.007.
- 3 Berzigotti A, Seijo S, Reverter E, Bosch J. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol 2013; 7 (02) 141-155 DOI: 10.1586/egh.12.83.
- 4 Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Practice Guidelines Committee of the American Association for the Study of Liver Diseases, Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46 (03) 922-938 DOI: 10.1002/hep.21907.
- 5 Zhao JR, Wang GC, Hu JH, Zhang CQ. Risk factors for early rebleeding and mortality in acute variceal hemorrhage. World J Gastroenterol 2014; 20 (47) 17941-17948 DOI: 10.3748/wjg.v20.i47.17941.
- 6 ter Borg PC, Hollemans M, Van Buuren HR. et al. Transjugular intrahepatic portosystemic shunts: long-term patency and clinical results in a patient cohort observed for 3-9 years. Radiology 2004; 231 (02) 537-545 DOI: 10.1148/radiol.2312021797.
- 7 Orloff MJ, Duguay LR, Kosta LD. Criteria for selection of patients for emergency portacaval shunt. Am J Surg 1977; 134 (01) 146-152 DOI: 10.1016/0002-9610(77)90298-7.
- 8 Mikkelsen WP. Therapeutic portacaval shunt. Preliminary data on controlled trial and morbid effects of acute hyaline necrosis. Arch Surg 1974; 108 (03) 302-305 DOI: 10.1001/archsurg.1974.01350270036007.
- 9 Sauerbruch T, Wong F. Treatment of Oesophageal Varices in Liver Cirrhosis. Digestion 2019; 99 (04) 261-266 DOI: 10.1159/000492076.
- 10 Zanetto A, Garcia-Tsao G. Management of acute variceal hemorrhage. F1000 Res 2019; 8 :F1000 Faculty Rev-966 DOI: 10.12688/f1000research.18807.1.
- 11 Zhou Y, Zhang W, Zhang Z. et al. PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risks. Eur J Gastroenterol Hepatol 2020; 32 (09) 1235-1243 DOI: 10.1097/MEG.0000000000001686.
- 12 Eck.
- 13 Whipple AO. The Problem of Portal Hypertension in Relation to the Hepatosplenopathies. Ann Surg 1945; 122 (04) 449-475 DOI: 10.1097/00000658-194510000-00001.
- 14 Henderson JM, Anderson CD. The Surgical Treatment of Portal Hypertension. Clin Liver Dis (Hoboken) 2020; 15 (Suppl. 01) S52-S63 DOI: 10.1002/cld.877.
- 15 Mercado MA. Surgical treatment for portal hypertension. Br J Surg 2015; 102 (07) 717-718 DOI: 10.1002/bjs.9849.
- 16 Orloff MJ. Fifty-three years' experience with randomized clinical trials of emergency portacaval shunt for bleeding esophageal varices in Cirrhosis: 1958-2011. JAMA Surg 2014; 149 (02) 155-169 DOI: 10.1001/jamasurg.2013.4045.
- 17 Henderson JM, Boyer TD, Kutner MH. et al; DIVERT Study Group. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology 2006; 130 (06) 1643-1651 DOI: 10.1053/j.gastro.2006.02.008.
- 18 Resnick RH, Chalmers TC, Ishihara AM. et al. A controlled study of the prophylactic portacaval shunt. A final report. Ann Intern Med 1969; 70 (04) 675-688 DOI: 10.7326/0003-4819-70-4-675.
- 19 Orloff MJ, Charters III AC, Chandler JG. et al. Portacaval shunt as emergency procedure in unselected patients with alcoholic cirrhosis. Surg Gynecol Obstet 1975; 141 (01) 59-68
- 20 Kirby R, Burke FD, Jones JD. Emergency and elective surgical treatment of portal hypertension. A review of 23 years' experience. Ann R Coll Surg Engl 1975; 57 (03) 148-158
- 21 Orloff MJ, Bell Jr RH, Hyde PV, Skivolocki WP. Long-term results of emergency portacaval shunt for bleeding esophageal varices in unselected patients with alcoholic cirrhosis. Ann Surg 1980; 192 (03) 325-340 DOI: 10.1097/00000658-198009000-00008.
- 22 Cameron JL, Maddrey WC. Mesoatrial shunt: a new treatment for the Budd-Chiari syndrome. Ann Surg 1978; 187 (04) 402-406 DOI: 10.1097/00000658-197804000-00010.
- 23 Millikan Jr WJ, Henderson JM, Sewell CW. et al. Approach to the spectrum of Budd-Chiari syndrome: which patients require portal decompression?. Am J Surg 1985; 149 (01) 167-176 DOI: 10.1016/s0002-9610(85)80028-3.
- 24 Chezmar JL, Bernardino ME. Mesoatrial shunt for the treatment of Budd-Chiari syndrome: radiologic evaluation in eight patients. AJR Am J Roentgenol 1987; 149 (04) 707-710 DOI: 10.2214/ajr.149.4.707.
- 25 Slakey DP, Klein AS, Venbrux AC, Cameron JL. Budd-Chiari syndrome: current management options. Ann Surg 2001; 233 (04) 522-527 DOI: 10.1097/00000658-200104000-00007.
- 26 Sarfeh IJ, Rypins EB, Mason GR. A systematic appraisal of portacaval H-graft diameters. Clinical and hemodynamic perspectives. Ann Surg 1986; 204 (04) 356-363 DOI: 10.1097/00000658-198610000-00003.
- 27 Collins JC, Ong MJ, Rypins EB, Sarfeh IJ. Partial portacaval shunt for variceal hemorrhage: longitudinal analysis of effectiveness. Arch Surg 1998; 133 (06) 590-592 , discussion 592–594 DOI: 10.1001/archsurg.133.6.590.
- 28 Sarfeh IJ, Rypins EB. Partial versus total portacaval shunt in alcoholic cirrhosis. Results of a prospective, randomized clinical trial. Ann Surg 1994; 219 (04) 353-361 DOI: 10.1097/00000658-199404000-00005.
- 29 Warren WD, Zeppa R, Fomon JJ. Selective trans-splenic decompression of gastroesophageal varices by distal splenorenal shunt. Ann Surg 1967; 166 (03) 437-455 DOI: 10.1097/00000658-196709000-00011.
- 30 Warren WD, Millikan Jr WJ, Henderson JM. et al. Ten years portal hypertensive surgery at Emory. Results and new perspectives. Ann Surg 1982; 195 (05) 530-542 DOI: 10.1097/00000658-198205000-00002.
- 31 Potts III JR, Henderson JM, Millikan Jr WJ, Warren WD. Emergency distal splenorenal shunts for variceal hemorrhage refractory to nonoperative control. Am J Surg 1984; 148 (06) 813-816 DOI: 10.1016/0002-9610(84)90444-6.
- 32 Millikan Jr WJ, Warren WD, Henderson JM. et al. The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding. Ten year follow-up. Ann Surg 1985; 201 (06) 712-722 DOI: 10.1097/00000658-198506000-00007.
- 33 Langer B, Taylor BR, Mackenzie DR, Gilas T, Stone RM, Blendis L. Further report of a prospective randomized trial comparing distal splenorenal shunt with end-to-side portacaval shunt. An analysis of encephalopathy, survival, and quality of life. Gastroenterology 1985; 88 (02) 424-429 DOI: 10.1016/0016-5085(85)90502-5.
- 34 Warren WD, Henderson JM, Millikan WJ, Galambos JT, Bryan FC. Management of variceal bleeding in patients with noncirrhotic portal vein thrombosis. Ann Surg 1988; 207 (05) 623-634 DOI: 10.1097/00000658-198805000-00017.
- 35 Henderson JM, Kutner MH, Millikan Jr WJ. et al. Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis. A prospective, randomized trial. Ann Intern Med 1990; 112 (04) 262-269 DOI: 10.7326/0003-4819-112-4-262.
- 36 Jin GL, Rikkers LF. Selective variceal decompression: current status. HPB Surg 1991; 5 (01) 1-15 DOI: 10.1155/1991/19213.
- 37 Rikkers LF, Jin G, Burnett DA, Buchi KN, Cormier RA. Shunt surgery versus endoscopic sclerotherapy for variceal hemorrhage: late results of a randomized trial. Am J Surg 1993; 165 (01) 27-32 , discussion 32–33 DOI: 10.1016/s0002-9610(05)80400-3.
- 38 Orozco H, Mercado MA, Granados Garcia J. et al. Selective shunts for portal hypertension: current role of a 21-year experience. Liver Transpl Surg 1997; 3 (05) 475-480 DOI: 10.1002/lt.500030501.
- 39 Orloff MJ, Isenberg JI, Wheeler HO. et al. Randomized trial of emergency endoscopic sclerotherapy versus emergency portacaval shunt for acutely bleeding esophageal varices in cirrhosis. J Am Coll Surg 2009; 209 (01) 25-40 DOI: 10.1016/j.jamcollsurg.2009.02.059.
- 40 Orloff MJ, Vaida F, Haynes KS, Hye RJ, Isenberg JI, Jinich-Brook H. Randomized controlled trial of emergency transjugular intrahepatic portosystemic shunt versus emergency portacaval shunt treatment of acute bleeding esophageal varices in cirrhosis. J Gastrointest Surg 2012; 16 (11) 2094-2111 DOI: 10.1007/s11605-012-2003-6.
- 41 Orloff MJ, Hye RJ, Wheeler HO. et al. Randomized trials of endoscopic therapy and transjugular intrahepatic portosystemic shunt versus portacaval shunt for emergency and elective treatment of bleeding gastric varices in cirrhosis. Surgery 2015; 157 (06) 1028-1045 DOI: 10.1016/j.surg.2014.12.003.
- 42 Rosemurgy AS, Goode SE, Zwiebel BR, Black TJ, Brady PG. A prospective trial of transjugular intrahepatic portasystemic stent shunts versus small-diameter prosthetic H-graft portacaval shunts in the treatment of bleeding varices. Ann Surg 1996; 224 (03) 378-384 , discussion 384–386 DOI: 10.1097/00000658-199609000-00014.
- 43 Rosemurgy AS, Frohman HA, Teta AF, Luberice K, Ross SB. Prosthetic H-graft portacaval shunts vs transjugular intrahepatic portasystemic stent shunts: 18-year follow-up of a randomized trial. J Am Coll Surg 2012; 214 (04) 445-453 , discussion 453–455 DOI: 10.1016/j.jamcollsurg.2011.12.042.
- 44 Rosemurgy AS, Serafini FM, Zweibel BR. et al. Transjugular intrahepatic portosystemic shunt vs. small-diameter prosthetic H-graft portacaval shunt: extended follow-up of an expanded randomized prospective trial. J Gastrointest Surg 2000; 4 (06) 589-597 DOI: 10.1016/s1091-255x(00)80107-9.
- 45 Ockenga J, Kroencke TJ, Schuetz T. et al. Covered transjugular intrahepatic portosystemic stents maintain lower portal pressure and require fewer reinterventions than uncovered stents. Scand J Gastroenterol 2004; 39 (10) 994-999 DOI: 10.1080/00365520410003443.
- 46 Maleux G, Nevens F, Wilmer A. et al. Early and long-term clinical and radiological follow-up results of expanded-polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures. Eur Radiol 2004; 14 (10) 1842-1850 DOI: 10.1007/s00330-004-2359-4.
- 47 Charon JP, Alaeddin FH, Pimpalwar SA. et al. Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol 2004; 15 (11) 1219-1230 DOI: 10.1097/01.RVI.0000137434.19522.E5.
- 48 Tripathi D, Ferguson J, Barkell H. et al. Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents. Eur J Gastroenterol Hepatol 2006; 18 (03) 225-232 DOI: 10.1097/00042737-200603000-00001.
- 49 Bureau C, Garcia Pagan JC, Layrargues GP. et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int 2007; 27 (06) 742-747 DOI: 10.1111/j.1478-3231.2007.01522.x.
- 50 Bureau C, Garcia-Pagan JC, Otal P. et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 2004; 126 (02) 469-475 DOI: 10.1053/j.gastro.2003.11.016.
- 51 Perarnau JM, Le Gouge A, Nicolas C. et al; STIC-TIPS group. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial. J Hepatol 2014; 60 (05) 962-968 DOI: 10.1016/j.jhep.2014.01.015.
- 52 Gur I, Diggs BS, Orloff SL. Surgical portosystemic shunts in the era of TIPS and liver transplantation are still relevant. HPB (Oxford) 2014; 16 (05) 481-493 DOI: 10.1111/hpb.12163.
- 53 Hosokawa I, Adam R, Allard MA. et al. Outcomes of surgical shunts and transjugular intrahepatic portasystemic stent shunts for complicated portal hypertension. Br J Surg 2017; 104 (04) 443-451 DOI: 10.1002/bjs.10431.
- 54 Sen I, Yohanathan L, Kärkkäinen JM, Nagorney DM. Current Indications and Long-Term Outcomes of Surgical Portosystemic Shunts in Adults. J Gastrointest Surg 2021; 25 (06) 1437-1444 DOI: 10.1007/s11605-020-04643-1.